G1 Therapeutics (GTHX) shares slumped nearly 55% Monday premarket after the company said its treatment candidate for metastatic triple negative breast cancer failed to achieve statistical significance in a late-stage trial and that it will wind down the program.
BitFuFu (FUFU) shares retreated 21%, paring Friday's rally.
ResMed (RMD) shares fell 11% following a 3.5% loss in the previous session.
Iris Energy Limited (IREN) shares dropped 6%, adding to Friday's 4.5% loss.
MicroStrategy (MSTR) shares were down 5% following a 1.3% increase in the previous session.
Price: 1.1200, Change: -1.36, Percent Change: -54.84
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments